Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis

OBJECTIVE: To explore the safety and effectiveness of high-dose cyclophosphamide (HiCy) without bone marrow transplantation in patients with aggressive multiple sclerosis (MS). DESIGN: A 2-year open-label trial of patients with aggressive relapsing-remitting multiple sclerosis (RRMS) given an immuno...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Krishnan, Chitra, Kaplin, Adam I., Brodsky, Robert A., Drachman, Daniel B., Jones, Richard J., Pham, Dzung L., Richert, Nancy D., Pardo, Carlos A., Yousem, David M., Hammond, Edward, Quigg, Megan, Trecker, Carrilin, McArthur, Justin C., Nath, Avindra, Greenberg, Benjamin M., Calabresi, Peter A., Kerr, Douglas A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2574697/
https://ncbi.nlm.nih.gov/pubmed/18541787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.65.8.noc80042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados